Cognitive Function and Brain Connectivity in CAS Patients:a Rs-fMRI Study

Sponsor
First Affiliated Hospital of Zhejiang University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05292729
Collaborator
(none)
30
1
7
4.3

Study Details

Study Description

Brief Summary

This is a prospective study aimed to explore the changes of cognitive function after surgery for CAS and the correlation with brain connectivity, in order to look for the clinical biomarkers to predict the carotid stent implantation for patients which can effect the cognition

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Carotid artery stenting (CAS) can significantly decrease the incidence of ischemic stroke in patients with severe carotid artery stenosis has been confirmed in large randomized controlled studies (1, 2).Previous studies showed carotid artery stenosis is closely related to cognitive dysfunction, including asymptomatic carotid artery stenosis(≥70%).Cognitive impairment is one of the most serious problem facing the elderly. The impact on cognitive function in patients with CAS has been discussed by many researchers, however the effect still remained conflicting.

    In past few years, several imaging techniques, such as resting-state functional MRI (R-fMRI), had been increasingly used to study cognitive impairment in humans. In this study, we evaluated the cognition performance in severe carotid artery stenosis patients undergoing CAS and explored the mechanisms underlying the cognition changes by the Rs-fMRI.

    Inclusion criteria:
    • age between 55 years and 80 years

    • unilateral internal carotid artery stenotic degree ≥ 70%

    • right-hand-dominant

    • free of dementia, and depression

    • modified Rankin Scale: 0 or 1

    • education ≥6 years

    • obtained written informed consent.

    Exclusion criteria:
    • contralateral internal carotid artery stenosis ≥ 50%

    • posterior circulation diseases

    • MMSE < 26, which is a cut-off value for mild cognitive impairment

    • severe systemic diseases and neuropsychiatric diseases (such as congestive heart failure)

    • any contraindications for MRI scan (e.g., metal implants)

    • Non atherosclerotic stenosis, such as dissection, vasculitis.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Cognitive Function and Brain Connectivity in Carotid Artery Stenting Patients:a Rs-fMRI Study
    Actual Study Start Date :
    Dec 1, 2021
    Anticipated Primary Completion Date :
    Jun 30, 2022
    Anticipated Study Completion Date :
    Jul 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Montreal Cognitive Assessment, MOCA [before CAS(within 1 week)]

      use MOCA to assess the cognition before CAS

    2. Mini-mental State Examination,MMSE [before CAS(within 1 week)]

      use MMSE to assess the cognition before CAS

    3. Montreal Cognitive Assessment, MOCA [3 months after CAS]

      use MOCA to assess the cognition after CAS

    4. Mini-mental State Examination,MMSE [3 months after CAS]

      use MMSE to assess the cognition after CAS

    Secondary Outcome Measures

    1. Digit Symbol Test [before CAS(within 1 week)]

      use to assess the cognition before CAS

    2. Digit Symbol Test [3 months after CAS]

      use to assess the cognition after CAS

    3. Trail Making Test A/B [before CAS(within 1 week)]

      use to assess the cognition before CAS

    4. Trail Making Test A/B [3 months after CAS]

      use to assess the cognition after CAS

    5. digital span test [before CAS(within 1 week)]

      use to assess the cognition before CAS

    6. digital span test [3 months after CAS]

      use to assess the cognition after CAS

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • age between 55 years and 80 years

    • unilateral internal carotid artery stenotic degree ≥ 70%

    • right-hand-dominant

    • free of stroke, TIA, dementia, and depression

    • modified Rankin Scale: 0 or 1

    • education ≥6 years

    • obtained written informed consent.

    Exclusion Criteria:
    • contralateral internal carotid artery stenosis ≥ 50%

    • posterior circulation diseases

    • MMSE < 26, which is a cut-off value for mild cognitive impairment

    • severe systemic diseases and neuropsychiatric diseases (such as congestive heart failure and history of stroke)

    • any contraindications for MRI scan (e.g., metal implants)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 the first affiliated hospital of Zhejiang university Hangzhou Zhejiang China 310016

    Sponsors and Collaborators

    • First Affiliated Hospital of Zhejiang University

    Investigators

    • Principal Investigator: Benyan Luo, PhD, Zhejiang University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    First Affiliated Hospital of Zhejiang University
    ClinicalTrials.gov Identifier:
    NCT05292729
    Other Study ID Numbers:
    • 3.0T rs-fMRI
    First Posted:
    Mar 23, 2022
    Last Update Posted:
    Mar 23, 2022
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by First Affiliated Hospital of Zhejiang University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 23, 2022